Drug Detail

Information about Nivolumab + BMS-986016

Generic Name	Nivolumab + BMS-986016
IND	BMS-936558 + BMS-986016
Brand Name (US)
Manufacturer	Bristol-Myers Squibb
Drug Type
Delivery	Intravenous
Approval Status	One is approved, the other is not
Indications
Overall Strategy
Strategy
Drug Category	PD-1 + LAG-3 Inhibitor

Links
Trials of this drug
	Safety Study of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors

Trial results